Published in Blood Weekly, April 26th, 2001
The goal of the research is to design biocompatible synthetic blood vessels that promote smooth, even blood flow.
If successful, the research, which is now in the virtual prototyping stage, would be a boon for patients whose blood vessels are damaged or partially occluded, such as patients at risk of stroke due to arterial plaque buildup, or dialysis patients who must endure...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.